Robert Hollingsworth, Ph.D., a former Pfizer executive who oversaw the development of cancer vaccines and immunotherapeutics, has taken on the role of the chief scientific officer at Shoreline Biosciences. Hollingsworth will be responsible for driving the development of Shoreline’s next-generation cellular immunotherapies based on induced pluripotent stem cells (iPSCs). The company’s drug candidates are being developed with Shoreline’s iPSC-derived natural […]

Two years ago, almost without warning, a global pandemic shook the world, and in an instant, made its citizens reconsider and reassess what is most important to us. Fear and forced isolation put family, friends and work-life balance at the top of this reassessment, and corporations now have some reevaluating of their own to do […]

Shoreline Biosciences has poached the leader of Pfizer’s cancer vaccines unit, Robert Hollingsworth, Ph.D., to serve as chief scientific officer for the startup, which has recently beefed up its leadership, financing and partnerships. Hollingsworth was chief scientific officer and vice president of cancer vaccines and immunotherapies at the New York Big Pharma, where he helped bring […]